Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 135 | 0 | 0 | 308 | 860 |
| Gross Profit | 135 | N/A | N/A | 308 | 860 |
| Operating Expenses | 37,566 | 23,199 | 19,359 | 16,192 | 15,659 |
| Operating Income | -37,431 | -23,199 | -19,359 | -15,884 | -14,799 |
| Other Income | -389 | 38 | 366 | 504 | 470 |
| Pre-tax Income | -37,820 | -23,161 | -18,993 | -15,380 | -14,329 |
| Income Tax | N/A | N/A | N/A | -176 | -251 |
| Net Income Continuous | -37,820 | -23,161 | -18,993 | -15,204 | -14,078 |
| Net Income | $-37,820 | $-23,161 | $-18,993 | $-15,204 | $-14,078 |
| EPS Basic Total Ops | -0.62 | -0.41 | -0.35 | -0.28 | -0.17 |
| EPS Basic Continuous Ops | -0.62 | -0.41 | -0.35 | -0.28 | -0.16 |
| EPS Diluted Total Ops | -0.62 | -0.41 | -0.35 | -0.28 | -0.17 |
| EPS Diluted Continuous Ops | -0.62 | -0.41 | -0.35 | -0.28 | -0.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.41 | -0.35 | -0.28 | -0.26 |
| EBITDA(a) | $-37,337 | $-23,106 | $-19,272 | $-15,808 | $-14,723 |